Related Experiment Video
Updated: May 1, 2026

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
Published on: April 29, 2022
The pseudophosphatase MK-STYX physically and genetically interacts with the mitochondrial phosphatase PTPMT1
Natalie M Niemi1, Juliana L Sacoman1, Laura M Westrate1
1Laboratory of Systems Biology, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.
Abstract:
We previously performed an RNA interference (RNAi) screen and found that the knockdown of the catalytically inactive phosphatase, MK-STYX [MAPK (mitogen-activated protein kinase) phospho-serine/threonine/tyrosine-binding protein], resulted in potent chemoresistance. Our follow-up studies demonstrated that knockdown of MK-STYX prevents cells from undergoing apoptosis through a block in cytochrome c release, but that MK-STYX does not localize proximal to the molecular machinery currently known to control this process. In an effort to define its molecular mechanism, we utilized an unbiased proteomics approach to identify proteins that interact with MK-STYX. We identified the mitochondrial phosphatase, PTPMT1 (PTP localized to mitochondrion 1), as the most significant and unique interaction partner of MK-STYX. We previously reported that knockdown of PTPMT1, an important component of the cardiolipin biosynthetic pathway, is sufficient to induce apoptosis and increase chemosensitivity. Accordingly, we hypothesized that MK-STYX and PTPMT1 interact and serve opposing functions in mitochondrial-dependent cell death. We confirmed that MK-STYX and PTPMT1 interact in cells and, importantly, found that MK-STYX suppresses PTPMT1 catalytic activity. Furthermore, we found that knockdown of PTPMT1 resensitizes MK-STYX knockdown cells to chemotherapeutics and restores the ability to release cytochrome c. Taken together, our data support a model in which MK-STYX controls apoptosis by negatively regulating PTPMT1. Given the important role of PTPMT1 in the production of cardiolipin and other phospholipids, this raises the possibility that dysregulated mitochondrial lipid metabolism may facilitate chemoresistance.
Insights
MK-STYX, a phosphatase, prevents apoptosis and chemoresistance by suppressing PTPMT1 activity. Restoring PTPMT1 function re-sensitizes cells to chemotherapy, revealing a novel mechanism in mitochondrial cell death and chemoresistance.
Area of Science:
- Cell Biology
- Biochemistry
- Molecular Oncology
Background:
- Mitogen-activated protein kinase (MAPK) phospho-serine/threonine/tyrosine-binding protein (MK-STYX) is a catalytically inactive phosphatase.
- MK-STYX knockdown confers chemoresistance by inhibiting apoptosis and cytochrome c release.
- The precise molecular mechanism of MK-STYX in regulating apoptosis remains undefined.
Purpose of the Study:
- To elucidate the molecular mechanism by which MK-STYX regulates apoptosis and chemoresistance.
- To identify proteins interacting with MK-STYX using an unbiased proteomics approach.
- To investigate the functional relationship between MK-STYX and its interaction partners in mitochondrial cell death.
Main Methods:
- RNA interference (RNAi) screening to identify genes involved in chemoresistance.
- Unbiased proteomics to identify MK-STYX interacting proteins.
- Co-immunoprecipitation to confirm protein interactions.
- Assessment of apoptosis, cytochrome c release, and chemosensitivity.
- Enzyme activity assays to determine the effect of MK-STYX on PTPMT1.
Main Results:
- Proteomics identified the mitochondrial phosphatase PTPMT1 (PTP localized to mitochondrion 1) as a key interaction partner of MK-STYX.
- MK-STYX and PTPMT1 interact in cells, and MK-STYX suppresses PTPMT1 catalytic activity.
- Knockdown of PTPMT1 in MK-STYX knockdown cells restored chemosensitivity and cytochrome c release.
- MK-STYX negatively regulates PTPMT1, impacting mitochondrial-dependent cell death.
Conclusions:
- MK-STYX controls apoptosis and chemoresistance by inhibiting the catalytic activity of PTPMT1.
- This interaction suggests a novel regulatory axis in mitochondrial cell death pathways.
- Dysregulation of mitochondrial lipid metabolism, influenced by PTPMT1, may contribute to chemoresistance, offering potential therapeutic targets.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
ATP Synthase: Mechanism
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Microtubule Associated Proteins (MAPs)
ATP Synthase: Structure

